Sciotti Richard J, Pliushchev Marina, Wiedeman Paul E, Balli Darlene, Flamm Robert, Nilius Angela M, Marsh Kennan, Stolarik DeAnne, Jolly Robert, Ulrich Roger, Djuric Stevan W
Abbott Laboratories, Infectious Disease Research, Department 47N, Abbott Park, IL 60064, USA.
Bioorg Med Chem Lett. 2002 Aug 19;12(16):2121-3. doi: 10.1016/s0960-894x(02)00352-9.
A novel series of antimicrobials of the oxazolidinone class is disclosed. These compounds are characterized relative to previously described analogues by a 'halostilbene-derived' pharmacophore and demonstrate enhanced antimicrobial activity against key Gram-positive pathogens when compared to Linezolid.
公开了一系列新型的恶唑烷酮类抗菌剂。相对于先前描述的类似物,这些化合物的特征在于具有“卤代芪衍生的”药效基团,并且与利奈唑胺相比,对关键革兰氏阳性病原体表现出增强的抗菌活性。